| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 760.80 | 0.7% |
| Total Income | 782.90 | 0.2% |
| Expenditure | 630.80 | 0.2% |
| PBT | 152.10 | 1.9% |
| Net Profit | 116.40 | 1.0% |
| OPM | 20.41% | 0.89pp |
| NPM | 14.87% | 0.18pp |
| EPS | 4.86 | 1.0% |
Indegene Achieves 1.8% QoQ Revenue Growth (USD), Unlocks Revenue Potential from Tectonic
31 Jul 2025 · 31 Jul 2025, 06:32 pm
Summary
Indegene, a digital-first life sciences commercialization company, announced its financial results for the quarter ended June 30, 2025. The company achieved a revenue of $88.9 million, reflecting 1.8% growth QoQ (USD). It maintained a strong and stable profitability profile with an EBITDA margin of 20.2% and a PAT margin of 15.3%. Indegene unlocks revenue potential from its strategic initiative ‘Tectonic’, its efforts to move upstream along the marketing value chain in the commercial content creation space.
Key Highlights
- 1
Achieved revenue of $88.9 million, reflecting 1.8% growth QoQ (USD)
- 2
Maintained a strong and stable profitability profile, with an EBITDA margin of 20.2% and a PAT margin of 15.3%
- 3
Unlocks revenue potential from its strategic initiative ‘Tectonic’
Management Comments
Manish Gupta
Chairman and CEO, Indegene
We continued our growth momentum in Q1FY26, delivering 1.8% growth QoQ in USD. This reflects a strong start to the year and indicates good traction with our clients and from recent deal wins. This was a good quarter for new pipeline growth, and we maintained the momentum on deal wins as well.
Suhas Prabhu
CFO, Indegene
In Q1FY26, we maintained our trajectory of stable and profitable growth. Both EBITDA margins and PAT margins were on stable lines, even as we continued investing on scaling Tectonic engagements which allow us to move upstream in the marketing value chain; these have now started to generate revenue for us. We have a strong cash position and balance sheet and remain focused on M&A opportunities.
Informational and educational content only. Not investment advice.